As examples of clinically used compounds with known cardioporotective activity in ischemia, ramipril (ACE inhibitor) and azilsartan (angiotensin II receptor blocker)34–36 were identified as drugs promoting viability of the cardiomyocytes. This evidence concerns the gene ACE and ischemia.